The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prevalence of EGFR mutations in patients with resected stage I-III non-squamous NSCLC: Results from the EARLY-EGFR study.
 
Ross A. Soo
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck; Merck Serono; Novartis; Pfizer; Puma Biotechnology; Roche/Genentech; Takeda; Yuhan
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Lilly; Merck; Merck Serono; Novartis; Pfizer; Puma Biotechnology; Roche/Genentech; Taiho Pharmaceutical; Takeda; Thermo Fisher Scientific; Yuhan
Research Funding - AstraZeneca; Boehringer Ingelheim
 
Thanyanan Reungwetwattana
Honoraria - AstraZeneca; BMS GmbH & Co. KG; MSD; Novartis; Pfizer; Roche; Takeda; Yuhan
Consulting or Advisory Role - AstraZeneca; BMS GmbH & Co. KG; MSD; Novartis; Pfizer; Roche; Takeda; Yuhan
Speakers' Bureau - AstraZeneca; BMS GmbH & Co. KG; MSD; Novartis; Pfizer; Roche; Takeda
Research Funding - AstraZeneca (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Yuhan (Inst)
 
Herman Andres Perroud
Leadership - Rosario
Research Funding - Argentinian National Cancer Agency (Inst)
Travel, Accommodations, Expenses - Pfizer; Raffo; Varifarma
 
Ullas Batra
Research Funding - Pfizer
 
Saadettin Kilickap
No Relationships to Disclose
 
Luis Fernando Tejado Gallegos
Employment - AstraZeneca
 
Natalia Donner
Employment - AstraZeneca
 
Mohamed Alsayed
Employment - AstraZeneca
 
Reto Huggenberger
Employment - AstraZeneca
Stock and Other Ownership Interests - Adaptimmune; Allogene Therapeutics; Arcutis Biotherapeutics; AstraZeneca; Blueprint Medicines; Chinook Therapeutics; Compugen; Cullinan Oncology; GlaxoSmithKline; Gritstone Bio; Haleon; Imugene; Innate Pharma; Seagen; SOBI; TG Therapeutics
 
Tu Van Dao
Honoraria - AstraZeneca; Merck Serono; MSD; Novartis; Pierre Fabre; Roche
Consulting or Advisory Role - AstraZeneca; MSD; Novartis